Internal Medicine, Hematology & Oncology · Baytown, TX
NPI
1598952178
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
1610 W Baker Rd
Baytown, TX, 77521
Phone (281) 837-2288
Groups this clinician bills Medicare through
Medicare paid, 2024
$633K
71,166 services
Medicare patients, 2024
535
Average age 69
Drug cost, 2024
$10.1M
3,071 prescriptions
Company payments, 2025
$2,496
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amir A Rasheed was code J1756 (injection, iron sucrose, 1 mg), 24,600 times for 47 patients. In total Amir A Rasheed billed 71,166 services in 67 codes, and Medicare paid $633K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 24,600 | 47 | $0.17 | $4,186 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 4,360 | 15 | $5.72 | $25K |
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 1,750 | 26 | $1.71 | $2,987 |
| 99232 Hospital E&M - Subsequent | Facility | 1,418 | 228 | $62.49 | $89K |
| 85025 Blood Count | Office | 1,139 | 268 | $7.55 | $8,603 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,070 | 15 | $0.09 | $96.92 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,040 | 16 | $0.25 | $264 |
| 99213 Office E&M - Established | Office | 667 | 227 | $65.40 | $44K |
| 96365 Intravenous Infusion, Hydration | Office | 491 | 84 | $46.93 | $23K |
| 96366 Intravenous Infusion, Hydration | Office | 433 | 73 | $15.22 | $6,591 |
| 99214 Office E&M - Established | Office | 343 | 120 | $88.51 | $30K |
| 99222 Hospital E&M - Initial | Facility | 266 | 235 | $101.87 | $27K |
| 96372 Injection Administration | Office | 195 | 25 | $11.14 | $2,173 |
| 96367 Intravenous Infusion, Hydration | Office | 141 | 17 | $22.30 | $3,144 |
| 36415 Venipuncture Blood Collection | Office | 137 | 40 | $8.65 | $1,185 |
By year: 2022 $802K for 78,433 services; 2023 $672K for 108,414 services; 2024 $633K for 71,166 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,139 | 268 | $7.55 | $8,603 |
| 36415 Venipuncture Blood Collection | 137 | 40 | $8.65 | $1,185 |
Medicare prescription drug claims, 2024
In 2024, the drug Amir A Rasheed prescribed most often to Medicare patients was Eliquis (Apixaban), with 415 prescriptions and refills. In total Amir A Rasheed wrote 3,071 Medicare prescriptions that cost $10.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 415 | 539 | 94 | $313K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 263 | 263 | 51 | $4,863 |
| Procrit Epoetin Alfa | 230 | 230 | 45 | $934K |
| Anastrozole Generic | 139 | 306 | 37 | $1,843 |
| Hydroxyurea Generic | 111 | 155 | 29 | $2,535 |
| Keytruda Pembrolizumab | 90 | 90 | Under 11 | $999K |
| Warfarin Sodium Generic | 82 | 130 | 12 | $335 |
| Bortezomib Generic | 67 | 67 | 12 | $21K |
| Jakafi Ruxolitinib Phosphate | 63 | 63 | Under 11 | $1.0M |
| Dexamethasone Generic | 61 | 63 | 15 | $1,489 |
| Lenalidomide Generic | 60 | 60 | Under 11 | $610K |
| Enoxaparin Sodium Generic | 58 | 58 | 24 | $12K |
| Gabapentin Generic | 56 | 56 | 19 | $261 |
| Prednisone Generic | 51 | 51 | 19 | $136 |
| Revlimid Lenalidomide | 51 | 51 | Under 11 | $760K |
Brand drugs: - claims; generic drugs: 1,693 claims; opioid claims: 355.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amir A Rasheed $2,496 ($2,496 in general payments such as food, travel and fees) from 38 companies. The largest payer was Pfizer Inc. with $276.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 13 | $276 |
| GlaxoSmithKline, LLC. GSK | 11 | $205 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $177 |
| Incyte Corporation INCY | 7 | $176 |
| Merck Sharp & Dohme LLC MRK | 7 | $155 |
| Astellas Pharma US Inc 4503.T | 5 | $138 |
| Sobi, Inc SOBI.ST | 3 | $126 |
| Rigel Pharmaceuticals, Inc. RIGL | 5 | $124 |
| Taiho Oncology, Inc. 4578.T | 4 | $91.38 |
| Eisai Inc. 4523.T | 4 | $83.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.